|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 125, Issue 13 2349-2358, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
A Rawls, MR Valdez, W Zhang, J Richardson, WH Klein and EN Olson
Department of Molecular Biology and Oncology, Department of Pathology, UT Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA.
The myogenic basic helix-loop-helix (bHLH) genes - MyoD, Myf5, myogenin and MRF4 - exhibit distinct, but overlapping expression patterns during development of the skeletal muscle lineage and loss-of-function mutations in these genes result in different effects on muscle development. MyoD and Myf5 have been shown to act early in the myogenic lineage to establish myoblast identity, whereas myogenin acts later to control myoblast differentiation. In mice lacking myogenin, there is a severe deficiency of skeletal muscle, but some residual muscle fibers are present in mutant mice at birth. Mice lacking MRF4 are viable and have skeletal muscle, but they upregulate myogenin expression, which could potentially compensate for the absence of MRF4. Previous studies in which Myf5 and MRF4 null mutations were combined suggested that these genes do not share overlapping myogenic functions in vivo. To determine whether the functions of MRF4 might overlap with those of myogenin or MyoD, we generated double mutant mice lacking MRF4 and either myogenin or MyoD. MRF4/myogenin double mutant mice contained a comparable number of residual muscle fibers to mice lacking myogenin alone and myoblasts from those double mutant mice formed differentiated multinucleated myotubes in vitro as efficiently as wild-type myoblasts, indicating that neither myogenin nor MRF4 is absolutely essential for myoblast differentiation. Whereas mice lacking either MRF4 or MyoD were viable and did not show defects in muscle development, MRF4/MyoD double mutants displayed a severe muscle deficiency similar to that in myogenin mutants. Myogenin was expressed in MRF4/MyoD double mutants, indicating that myogenin is insufficient to support normal myogenesis in vivo. These results reveal unanticipated compensatory roles for MRF4 and MyoD in the muscle differentiation pathway and suggest that a threshold level of myogenic bHLH factors is required to activate muscle structural genes, with this level normally being achieved by combinations of multiple myogenic bHLH factors.
This article has been cited by other articles:
|
|
 |
|
  S. A. Eaton, A. P. W. Funnell, N. Sue, H. Nicholas, R. C. M. Pearson, and M. Crossley A Network of Kruppel-like Factors (Klfs): Klf8 IS REPRESSED BY Klf3 AND ACTIVATED BY Klf1 IN VIVO J. Biol. Chem., October 3, 2008; 283(40): 26937 - 26947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hewitt, X. Lu, L. Gilbert, and M. S. Nanes The Muscle Transcription Factor MyoD Promotes Osteoblast Differentiation by Stimulation of the Osterix Promoter Endocrinology, July 1, 2008; 149(7): 3698 - 3707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Basu, T. K. Lung, W. Lemsaddek, T. G. Sargent, D. C. Williams Jr, M. Basu, L. C. Redmond, J. B Lingrel, J. L. Haar, and J. A. Lloyd EKLF and KLF2 have compensatory roles in embryonic {beta}-globin gene expression and primitive erythropoiesis Blood, November 1, 2007; 110(9): 3417 - 3425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chandran, T. J. Knobloch, M. Anghelina, and S. Agarwal Biomechanical signals upregulate myogenic gene induction in the presence or absence of inflammation Am J Physiol Cell Physiol, July 1, 2007; 293(1): C267 - C276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Knapp, J. K. Davie, A. Myer, E. Meadows, E. N. Olson, and W. H. Klein Loss of myogenin in postnatal life leads to normal skeletal muscle but reduced body size Development, February 15, 2006; 133(4): 601 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ishibashi, R. L. Perry, A. Asakura, and M. A. Rudnicki MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions J. Cell Biol., November 7, 2005; 171(3): 471 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Jones, D. J. Baker, S. M. Gardiner, T. Bennett, J. A. Timmons, and P. L. Greenhaff The Effect of the {beta}2-Adrenoceptor Agonist Prodrug BRL-47672 on Cardiovascular Function, Skeletal Muscle Myosin Heavy Chain, and MyoD Expression in the Rat J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1225 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Charbonnier, B. D. Gaspera, A.-S. Armand, S. Lecolle, T. Launay, C.-L. Gallien, and C. Chanoine Specific Activation of the Acetylcholine Receptor Subunit Genes by MyoD Family Proteins J. Biol. Chem., August 29, 2003; 278(35): 33169 - 33174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hadchouel, J. J. Carvajal, P. Daubas, L. Bajard, T. Chang, D. Rocancourt, D. Cox, D. Summerbell, S. Tajbakhsh, P. W. J. Rigby, et al. Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus Development, August 1, 2003; 130(15): 3415 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laclef, G. Hamard, J. Demignon, E. Souil, C. Houbron, and P. Maire Altered myogenesis in Six1-deficient mice Development, May 15, 2003; 130(10): 2239 - 2252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L'honore, N. J. Lamb, M. Vandromme, P. Turowski, G. Carnac, and A. Fernandez MyoD Distal Regulatory Region Contains an SRF Binding CArG Element Required for MyoD Expression in Skeletal Myoblasts and during Muscle Regeneration Mol. Biol. Cell, May 1, 2003; 14(5): 2151 - 2162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-r. Lu, R. Bassel-Duby, A. Hawkins, P. Chang, R. Valdez, H. Wu, L. Gan, J. M. Shelton, J. A. Richardson, and E. N. Olson Control of Facial Muscle Development by MyoR and Capsulin Science, December 20, 2002; 298(5602): 2378 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-Z. Wang, M. R. Valdez, J. McAnally, J. Richardson, and E. N. Olson The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development Development, November 15, 2001; 128(22): 4623 - 4633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Hawke and D. J. Garry Myogenic satellite cells: physiology to molecular biology J Appl Physiol, August 1, 2001; 91(2): 534 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Launay, A.-S. Armand, F. Charbonnier, J.-C. Mira, E. Donsez, C. L. Gallien, and C. Chanoine Expression and Neural Control of Myogenic Regulatory Factor Genes During Regeneration of Mouse Soleus J. Histochem. Cytochem., July 1, 2001; 49(7): 887 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Bergstrom and S. J. Tapscott Molecular Distinction between Specification and Differentiation in the Myogenic Basic Helix-Loop-Helix Transcription Factor Family Mol. Cell. Biol., April 1, 2001; 21(7): 2404 - 2412. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Graves and Z. Yablonka–Reuveni Vascular Smooth Muscle Cells Spontaneously Adopt a Skeletal Muscle Phenotype: A Unique Myf5-/MyoD+ Myogenic Program J. Histochem. Cytochem., September 1, 2000; 48(9): 1173 - 1194. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Spencer, S. Eliazer, R. L. Ilaria , Jr., J. A. Richardson, and E. N. Olson Regulation of Microtubule Dynamics and Myogenic Differentiation by MURF, a Striated Muscle RING-Finger Protein J. Cell Biol., August 21, 2000; 150(4): 771 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Naya, B. Mercer, J. Shelton, J. A. Richardson, R. S. Williams, and E. N. Olson Stimulation of Slow Skeletal Muscle Fiber Gene Expression by Calcineurin in Vivo J. Biol. Chem., February 18, 2000; 275(7): 4545 - 4548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Delfini, E Hirsinger, O Pourquie, and D Duprez Delta 1-activated notch inhibits muscle differentiation without affecting Myf5 and Pax3 expression in chick limb myogenesis Development, January 12, 2000; 127(23): 5213 - 5224. [Abstract] [PDF]
|
|
|
|
|
|
D Summerbell, P. Ashby, O Coutelle, D Cox, S Yee, and P. Rigby The expression of Myf5 in the developing mouse embryo is controlled by discrete and dispersed enhancers specific for particular populations of skeletal muscle precursors Development, January 9, 2000; 127(17): 3745 - 3757. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Lu, R. Webb, J. A. Richardson, and E. N. Olson MyoR: A muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD PNAS, January 19, 1999; 96(2): 552 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Wilson-Rawls, C. Hurt, S. Parsons, and A Rawls Differential regulation of epaxial and hypaxial muscle development by paraxis Development, January 12, 1999; 126(23): 5217 - 5229. [Abstract] [PDF]
|
|
|
|
|
|
H Peters, B Wilm, N Sakai, K Imai, R Maas, and R Balling Pax1 and Pax9 synergistically regulate vertebral column development Development, January 12, 1999; 126(23): 5399 - 5408. [Abstract] [PDF]
|
|
|
|
|
|
M. Thomas, B. Langley, C. Berry, M. Sharma, S. Kirk, J. Bass, and R. Kambadur Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation J. Biol. Chem., December 15, 2000; 275(51): 40235 - 40243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Hunter, M. F. van Delft, R. A. Rachubinski, and J. P. Capone Peroxisome Proliferator-activated Receptor gamma Ligands Differentially Modulate Muscle Cell Differentiation and MyoD Gene Expression via Peroxisome Proliferator-activated Receptor gamma -dependent and -independent Pathways J. Biol. Chem., October 5, 2001; 276(41): 38297 - 38306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Gao, T. Chandra, M.-O. Gratton, I. Quelo, J. Prud'homme, S. Stifani, and R. St-Arnaud HES6 acts as a transcriptional repressor in myoblasts and can induce the myogenic differentiation program J. Cell Biol., September 17, 2001; 154(6): 1161 - 1172. [Abstract] [Full Text] [PDF]
|
|
